US FDA E-cigarette Guidance as of 2020
Dasgupta N, Fiala SC. “Experimental Forum 1: The 2020 Food and Drug Administration Guidance on E-Cigarettes”, American Journal of Public Health 110, no. 6 (June 1, 2020): pp. 759-760. https://ajph.aphapublications.org/doi/10.2105/AJPH.2020.305684
This forum review discusses articles reflecting the strengths and weaknesses of FDA’s 2020 Guidance on E-Cigarettes. One can link to several articles including:
Gee RE. Shortcomings of the Food and Drug Administration Guidance Addressed by Congress 2020 HR 2339. American Journal of Public Health 110, no. 6 (June 1, 2020): pp. 776-777. Published online May 6, 2020.
“The regulatory gaps left unaddressed by the FDA guidance are clearly outlined in comments submitted to the FDA by a bipartisan group of 26 attorneys general in February. The FDA guidance does not apply to menthol vaping products and does not apply to refillable or sealed disposable vaping products, the latter of which are becoming increasingly popular among youths. The guidance also refers to vaping as a means of transitioning off traditional tobacco products, overlooking the fact that vaping products are not recognized as effective methods of tobacco cessation and therefore the FDA has not given any of them premarket authorization for that purpose.” https://doi.org/10.2105/AJPH.2020.305679
by Stephen Hamann
